March 23, 2019
A. Azam, V. Latman, J. Katz
BACKGROUND Mindfulness meditation is a commonly used psychological intervention for pain, mood, and anxiety conditions, but can be challenging to practice when dealing with severe symptoms without proper training experience. The Mindfulness Meditation App (MMA) is a supportive training tool specifically developed for the present study, to aid in the practice of mindful breathing using a...
ANIMA Indonesian Psychological Journal
March 21, 2019
Didon Permadi, Fivi Nurwianti
Competitive anxiety is one of the psychological factors which greatly affect athletes' performances. Competitive anxiety is divided into somatic anxiety and cognitive anxiety. This study was conducted to look at mindfulness and coping skills as predictors of competitive anxiety. Through purposive sampling techniques, some (N = 159) senior athletes, representatives of various sports from various...
International Clinical Neuroscience Journal
March 20, 2019
Shahin Fahiminia, Afshin Salahiyan, Mahtab Norouzi
Background: Cancer has many potential physical, psychological and social consequences for the patient. This single case study explored the efficiency of mindfulness therapy with the aid of virtual reality (VR) focusing on minimizing anxiety especially death anxiety in a patient with cerebellar cancer. Methods: In this case study research the patient met and consulted 3 times in the first week,...
Frontiers in Psychology
March 8, 2019
F. Parmentier, Mauro Garcia-Toro, Javier García-campayo et al.
The present study examined the effects of mindfulness on depression and anxiety, both direct and indirect through the mediation of four mechanisms of emotional regulation: worry, rumination, reappraisal and suppression. Path analysis was applied to data collected from an international and non-clinical sample of 1151 adults, including both meditators and non-meditators, who completed an online...
ACS Chemical Neuroscience
March 4, 2019
Lindsay P. Cameron, Charlie J. Benson, Brian C. Defelice et al.
163 citations
-dimethyltryptamine (DMT). The behavioral and cellular effects of this dosing regimen were distinct from those induced following a single high dose of the drug. We found that chronic, intermittent, low doses of DMT produced an antidepressant-like phenotype and enhanced fear extinction learning without impacting working memory or social interaction. Additionally, male rats treated with DMT on...
American Journal of Geriatric Psychiatry
March 1, 2019
Sophia Escobar
Introduction Approximately 10-20% of older adults treated in primary care settings suffer from symptoms of depression and/or anxiety. As our population ages, the number of older adults in primary care increases, and the urgent need to find cost-effective and efficient alternative therapies become crucial. The present RCT study aim was to investigate the effect of mindfulness-based cognitive...
Journal of the American Pharmacists Association
March 1, 2019
J. Perepelkin, Kristen Antunes, Luke Boechler et al.
OBJECTIVE The objective of this study was to assess the impact of mindfulness meditation offered in a community pharmacy on patients with current anxiety or a history of anxiety, depression, or both. SETTING Community pharmacy clinical space located in a grocery store. PRACTICE DESCRIPTION An 8-week, once-per-week mindfulness meditation program for patients with anxiety or depression. PRACTICE...
Journal of Affective Disorders
March 1, 2019
M. Carpena, P. Tavares, C. Menezes
BACKGROUND Evidence shows high prevalence of depression and anxiety symptoms among university students. This study investigated whether a meditation-based program would help reducing these symptoms in this population. METHODS Non-randomized controlled trial investigating the effects of a six-week focused meditation training on depression (Beck Depression Inventory) and anxiety (Beck Anxiety...
Journal of Psychedelic Studies
February 25, 2019
Jenna Varley
4 citations
Psychedelics have been investigated for their therapeutic applications in end-of-life care as early as 1960. Recently, there have been four main groups conducting clinical trials for either lysergic acid diethylamide or psilocybin for the treatment of anxiety and depression in patients with terminal illnesses. The recent trials have higher methodological quality and demonstrate the profound...
BioPsychoSocial Medicine
February 18, 2019
Toru Takahashi, F. Sugiyama, T. Kikai et al.
BackgroundMindfulness-based interventions are increasingly being implemented worldwide for problems with depression and anxiety, and they have shown evidence of efficacy. However, few studies have examined the effects of a mindfulness-based group therapy based on standard programs for depression and anxiety until follow-up in Japan. This study addresses that gap. Furthermore, this study...